<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">genort</journal-id><journal-title-group><journal-title xml:lang="ru">Гений ортопедии</journal-title><trans-title-group xml:lang="en"><trans-title>Genij Ortopedii</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1028-4427</issn><issn pub-type="epub">2542-131X</issn><publisher><publisher-name>ЦЕНТР ИЛИЗАРОВА</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">genort-1471</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original articles</subject></subj-group></article-categories><title-group><article-title>Влияние комплексного консервативного лечения на уровень сывороточных цитокинов у больных с I-II стадиями остеоартроза крупных суставов</article-title><trans-title-group xml:lang="en"><trans-title>The effect of complex conservative treatment on the level of serum cytokines in patients with large joint osteoarthrosis of I-II stage</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аскаров</surname><given-names>С. Е.</given-names></name></name-alternatives><email xlink:type="simple"></email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Волокитина</surname><given-names>Е. А.</given-names></name></name-alternatives><email xlink:type="simple"></email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сазонова</surname><given-names>Н. В.</given-names></name></name-alternatives><email xlink:type="simple"></email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чепелева</surname><given-names>М. В.</given-names></name></name-alternatives><email xlink:type="simple"></email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Швед</surname><given-names>Н. С.</given-names></name></name-alternatives><email xlink:type="simple"></email></contrib></contrib-group><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>28</day><month>03</month><year>2009</year></pub-date><volume>0</volume><issue>1</issue><issue-title>№ 1 (2009)</issue-title><elocation-id>1471</elocation-id><permissions><copyright-statement>Copyright &amp;#x00A9; Аскаров С., Волокитина Е., Сазонова Н., Чепелева М., Швед Н., 2009</copyright-statement><copyright-year>2009</copyright-year><copyright-holder xml:lang="ru">Аскаров С., Волокитина Е., Сазонова Н., Чепелева М., Швед Н.</copyright-holder><copyright-holder xml:lang="en">Аскаров С., Волокитина Е., Сазонова Н., Чепелева М., Швед Н.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ilizarov-journal.com/jour/article/view/1471">https://www.ilizarov-journal.com/jour/article/view/1471</self-uri><abstract><p>Изучено влияние комплексного, патогенетически обоснованного консервативного лечения, включающего применение хондропротекторов, НПВП, препаратов кальция, физиотерапевтических процедур, ЛФК на уровень спонтанной продукции сывороточных цитокинов (IL-1β, TNFα, IL-6, IL-10) у 69 больных с остеоартрозом коленного и тазобедренного суставов I-II стадии. В группе пациентов с хорошими и удовлетворительными результатами лечения выявлено статистически значимое снижение уровня IL-1β в сроки 6-24 месяца, а также исходно повышенного уровня TNFα в сроки 12-24 месяца после начала консервативной терапии. При отсутствии терапевтического эффекта (сохранении болевого синдрома) отмечено кратковременное снижение уровня IL-1β через 6 месяцев, концентрации TNFα через 12 месяцев после начала курсового лечения. Полученные данные рекомендуется использовать для оценки эффективности лечебных мероприятий у пациентов с ранними стадиями остеоартроза крупных суставов в амбулаторно-поликлинических условиях.</p></abstract><trans-abstract xml:lang="en"><p>The effect of complex pathogenetically substantiated conservative treatment including the use of chondroprotectors, non-steroid anti-inflammatory preparations, calcium preparations, physiotherapeutic procedures, exercise therapy, on the level of spontaneous production of serum cytokines (IL-1β, TNFα, IL-6, IL-10) has been studied in 69 patients with I-II stage osteoarthrosis of the knee and the hip. The statistically significant decrease of IL-1β level within 6-24 months, as well as that of initially increased TNFα level in the periods of 12-24 months after conservative therapy start has been revealed in the group of patients with good and satisfactory results of treatment. In case of therapeutic effect absence (pain syndrome remaining) the short-term decrease of IL-1β level has been observed after 6 months and that of TNFα concentration after 12 months since treatment course start. The data obtained are recommended to be used for evaluation of the effectiveness of therapeutic measures in patients with early stages of large joint osteoarthrosis in out-patient conditions.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
